Learn more about the Teleport Team!

Teleport Pharmaceuticals

Drugs for the Brain from the Brain

Drugs for the Brain from the Brain

Endogenous neurotransmitters provide the starting point for Teleport Pharamceuticals' glycopeptide drugs for the treatment of degenerative neurological diseases. We are targeting neurogenerative diseases such as Alzheimer’s, Parkinson’s, and ALS or Lou Gehrig’s disease, as well as AIDS related neuropathy, diabetic neuropathy, autism, stroke and closed head injury. Teleport Pharmaceuticals is dedicated to novel peptide-based drug design for future therapeutics.

Get UpdatesContact Us
Founders of Teleport Pharmaceuticals

Main Content

Teleport Pharmaceuticals is the nexus of the groundbreaking research of three University of Arizona Professors, Professors Polt, Heien, and Streicher. Tucson, Arizona is home to the University of Arizona and a vibrant and supportive business and technology hub.

The supportive biotech ecosystem in Southern Arizona includes BIO5, Tech Launch Arizona, BIOSA, and dozens of cooperative companies and initiatives.